• Current and future management of CHB
• Liver transplant for HCV
• NASH in Asia-Pacific: what’s new?
• Pharmacologic management of NASH: Towards a new paradigm
• What AASLD-IDSA guidance says
• Guidance versus real life practice in the US
• Hepatitis C and transplantation: is it time to change our thinking?
• Hepatitis B Guidelines over the decades: Western perspective
• New paradigms in the management of HBV:
  Long Term & Stopping role in the management of NUC Therapy
• HBV-Pathobiology
• The management of lean NASH: No weight and no time to lose?